STATE OF WISCONSIN INVESTMENT BOARD - AMNEAL PHARMACEUTICALS INC ownership

AMNEAL PHARMACEUTICALS INC's ticker is AMRX and the CUSIP is 03168L105. A total of 144 filers reported holding AMNEAL PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.49 and the average weighting 0.0%.

Quarter-by-quarter ownership
STATE OF WISCONSIN INVESTMENT BOARD ownership history of AMNEAL PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$95,794
+453.0%
22,700
+82.2%
0.00%
Q1 2023$17,322
-90.6%
12,462
-86.6%
0.00%
-100.0%
Q4 2022$184,469
-7.3%
92,698
-5.8%
0.00%0.0%
Q3 2022$199,000
-39.7%
98,362
-5.3%
0.00%0.0%
Q2 2022$330,000
-43.1%
103,816
-25.4%
0.00%0.0%
Q1 2022$580,000
-12.9%
139,1000.0%0.00%0.0%
Q4 2021$666,000
-10.4%
139,1000.0%0.00%
-50.0%
Q3 2021$743,000
+4.4%
139,1000.0%0.00%
+100.0%
Q2 2021$712,000
-23.9%
139,1000.0%0.00%
-50.0%
Q1 2021$936,000
-3.0%
139,100
-34.1%
0.00%0.0%
Q4 2020$965,000
-6.7%
211,100
-20.8%
0.00%
-33.3%
Q3 2020$1,034,000
+7.7%
266,600
+32.2%
0.00%0.0%
Q2 2020$960,000
+51.2%
201,700
+10.5%
0.00%
+50.0%
Q1 2020$635,000
-6.2%
182,500
+29.9%
0.00%0.0%
Q4 2019$677,000
+66.3%
140,5000.0%0.00%
+100.0%
Q3 2019$407,000
-54.9%
140,500
+11.5%
0.00%
-66.7%
Q2 2019$903,000
-73.0%
126,000
-46.5%
0.00%
-66.7%
Q1 2019$3,340,000
+17.9%
235,700
+12.6%
0.01%0.0%
Q4 2018$2,832,000
-38.9%
209,300
+0.2%
0.01%
-30.8%
Q3 2018$4,633,000
+219.1%
208,800
+135.9%
0.01%
+225.0%
Q2 2018$1,452,00088,5000.00%
Other shareholders
AMNEAL PHARMACEUTICALS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Fosun International Ltd 21,521,301$103,087,0005.89%
Eversept Partners, LP 6,440,572$30,850,3401.97%
TPG GP A, LLC 16,213,367$77,662,0000.78%
Signature Wealth Management Partners, LLC 87,666$420,0000.36%
Hedges Asset Management LLC 75,000$359,0000.28%
Hillsdale Investment Management Inc. 869,916$4,167,0000.28%
Tranquilli Financial Advisor LLC 71,414$342,0000.24%
HUSSMAN STRATEGIC ADVISORS, INC. 180,000$862,0000.19%
GLOBEFLEX CAPITAL L P 297,414$1,424,0000.15%
XTX Topco Ltd 23,742$114,0000.06%
View complete list of AMNEAL PHARMACEUTICALS INC shareholders